Document Classification

Section Type: RESULTS

Text: Compared with placebo, enalaprilat decreased pulmonary capillary wedge pressure (-37 % versus -10 %, P =. 001), diastolic and mean systemic blood pressures (-21 % versus 0 %, P =. 009, and -18 % versus -1 %, P =. 026, respectively), diastolic and mean pulmonary blood pressures (-21 % versus -8 %, P =. 040 ; -18 % versus -9 %, P =. 046), and brachial and renal resistances (-44 % versus -14 %, P =. 017, and -22 % versus -2 %, P =. 014, respectively) ; increased brachial and renal blood flows (+77 % versus +8 %, P =. 036, and +12 % versus 0 %, P =. 043, respectively), arterial oxygen tension (+2 % versus -16 %, P =. 041), and arterial oxygen saturation (+1 % versus -2 %, P =. 045) ; and tended to decrease rate-pressure product (-19 % versus -7 %, P =. 076), increase brachial artery diameter (+13 % versus 0 %, P =. 081), and improve intrapulmonary shunt (-18 % versus +16 %, P =. 080).